RESULTS
Study design and partnership agreement were outlined between September
2019 and January 2020. Patients from the study institution were screened
for participation between March-August 2020, alongside product design
and manufacture. Sixteen dogs fulfilled the inclusion criteria, and the
first owner’s telephone interview was held in September 2020.
Pre-clinical testing in healthy dogs occurred in early October 2020. The
clinical trial ran from October 2020 to April 2021. Laboratory
determinations and data analysis were subsequently undertaken.